ID: ALA1098471

Max Phase: Preclinical

Molecular Formula: C31H32N4

Molecular Weight: 460.63

Molecule Type: Small molecule

Representations

Canonical SMILES:  c1ccc2c(c1)c1ccncc1n2CCCCCCCCCn1c2ccccc2c2ccncc21

Standard InChI:  InChI=1S/C31H32N4/c1(2-4-10-20-34-28-14-8-6-12-24(28)26-16-18-32-22-30(26)34)3-5-11-21-35-29-15-9-7-13-25(29)27-17-19-33-23-31(27)35/h6-9,12-19,22-23H,1-5,10-11,20-21H2

Standard InChI Key:  JJAATQLWMKLMJU-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 460.63

Molecular Weight (Monoisotopic): 460.2627

AlogP: 8.12

#Rotatable Bonds: 10

Polar Surface Area: 35.64

Molecular Species: NEUTRAL

HBA: 4

HBD: 0

#RO5 Violations: 1

HBA (Lipinski): 4

HBD (Lipinski): 0

#RO5 Violations (Lipinski): 1

CX Acidic pKa:

CX Basic pKa: 5.46

CX LogP: 6.82

CX LogD: 6.82

Aromatic Rings: 6

Heavy Atoms: 35

QED Weighted: 0.19

Np Likeness Score: -0.38

References

1. Rook Y, Schmidtke KU, Gaube F, Schepmann D, Wünsch B, Heilmann J, Lehmann J, Winckler T..  (2010)  Bivalent beta-carbolines as potential multitarget anti-Alzheimer agents.,  53  (9): [PMID:20361801] [10.1021/jm1000024]

2. Otto R, Penzis R, Gaube F, Adolph O, Föhr KJ, Warncke P, Robaa D, Appenroth D, Fleck C, Enzensperger C, Lehmann J, Winckler T..  (2015)  Evaluation of Homobivalent Carbolines as Designed Multiple Ligands for the Treatment of Neurodegenerative Disorders.,  58  (16): [PMID:26278660] [10.1021/acs.jmedchem.5b00958]

Source

Source(1):

• Scientific Literature